首页 | 本学科首页   官方微博 | 高级检索  
     


Mass Screening for Neuroblastoma in Japan
Authors:Tadashi Sawada M.D.     Noboru Nagahara M.D.    Keiko Yamamoto M.D.    Ikuo Okabe M.D.    Yoshiyuki Hanawa M.D.    Kouhei Hashizume M.D.    Ichiro Matsui M.D.    Haruo Okawa M.D.    Akio Tsunoda M.D.    Minoru Sakurai M.D.    Kazuhiro Ueda M.D.    Shigeru Kimura M.D.    Akira Nakagawa M.D.    Yoshinobu Hata M.D.    Takeo Takeda M.D.   Ryoji Ohi M.D.
Affiliation:*Chairman;**Vice-chairmen;The Committee of the Neuroblastoma Mass Screening Study of the Japanese Society of Pediatric Oncology
Abstract:
The present status of NB mass screening in Japan, which is the first national trial in the world, is presented. This program was conducted in cooperation with infants' mothers, local health centers, screening centers and hospitals. Three hundred and thirty-seven cases detected by the program, from the start in Kyoto in 1974 to the end of 1989, are analyzed. As many cases were detected at early stages, 97% of them were expected to be cured. Several clinical, technical and programmatic problems are also discussed.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号